| ²é¿´: 4357 | »Ø¸´: 15 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
³ÕÃÎäìÏæÄ¾³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
Õý´óÌìÇç3000ÍòÃÀÔªÂòÈëÒ»¸öÁÙ´²Ç°¿¹HCVÒ©ÎïÔÚÖйúµØÇøµÄÐí¿É£¬Ìì¼Û? ÒÑÓÐ12È˲ÎÓë
|
|||
|
2013Äê6Ô£¬½ËÕÕý´óÌìÇç3000ÍòÃÀÔª»ñµÃBL-8030ÔÚÖйúºÍÏã¸ÛµÄÐí¿É¡£ http://www.biolinerx.com/default.asp?pageid=16&itemid=198 NS3/4Aµ°°×øÒÖÖÆ¼Á£ºBL-8030£¨ÁÙ´²Ç°£© Ñз¢µ¥Î»£ºBioLineRx Ltd. »¯ºÏÎï½á¹¹£ºÎ´¹«¿ª »¯ºÏÎïרÀû£ºÎ´¹«¿ª£¨2010ÄêÉêÇ룩 ÊÊÓ¦Ö¢£º±ûÐ͸ÎÑ× ×ÛºÏ×ÊÁÏ£ºBL-8030: A Novel, Potent, Selective, Orally Available Inhibitor of Hepatitis C Virus NS3/4A Protease. EASL 48th Annual Meeting, April 24th - 28th 2013 http://www.natap.org/2013/EASL/EASL_89.htm ÌåÍâ»îÐÔ£º £¨1£©Huh-7 cell based HCV replicon assay (qRT-PCR)£º BL-8030¶Ô»ùÒòÐÍ1a¡¢1bµÄ»îÐÔ·Ö±ðΪ5.2nm¡¢1.64nm£¬ÑôÐÔ¶ÔÕÕtelaprevirµÄ»îÐÔ·Ö±ðΪ10nm¡¢240nM£» BL-8030¶Ô»ùÒòÐÍ2aµÄ»îÐÔΪ168.25nm£¬ÑôÐÔ¶ÔÕÕboceprevirµÄ»îÐÔΪ217.35nm¡£ £¨2£©wild type and PI mutant enzymes£º ¶ÔÓÚ»ùÒòÐÍ1a£¬BL-8030¡¢telaprevir¡¢TMC-435µÄ»îÐÔ·Ö±ðΪ1.32nm¡¢111nm¡¢1.52nm£¬BL-8030¶ÔÓÚ1a¡¢1b¡¢2a¡¢3a¡¢4dµÄ»îÐÔ·Ö±ðΪ1.32nm¡¢1.00nm¡¢4.36nm¡¢158nm¡¢10.59nm£¬ÆäËû»îÐÔÊý¾Ý¼ûEASL2013Äê»á×ÊÁÏ£» ¶ÔÓÚ¶àÖÖ±äÒìÐ͵°°×ø£¬BL-8030µÄ»îÐÔÓëTMC-435Ï൱£¬Ô¶¸ßÓÚtelaprevir£¬¾ßÌå»îÐÔÊý¾Ý¼ûEASL2013Äê»á×ÊÁÏ£» £¨3£©human proteases£º BL-8030¶ÔÈ˵°°×øµÄ»îÐԺܵͣ¬ÓëvaniprevirÏ൱£¬Ñ¡ÔñÐÔÔ¶ÓÅÓÚtelaprevir£¬¾ßÌå»îÐÔÊý¾Ý¼ûEASL2013Äê»á×ÊÁÏ¡£ £¨4£©Human cytochrome P450 enzyme£º BL-8030¶ÔÖ÷ÒªCYPÎÞÒÖÖÆ»îÐÔ¡£ PK£º ´óÊó10mg/kg¡¢100mg/kgµ¥´Î¸øÒ©¿Ú·þÉúÎïÀûÓöȷֱðΪ17.4%¡¢33.7%¡£ Liver/plasmaÒ©Îï·Ö²¼±ÈÔÚ28.4ÖÁ45.4¡£ ¸øÒ©24Сʱºó£¬ÑªÒ©Å¨¶È¸ßÓÚEC50£¬Ö§³ÖÿÌì¿Ú·þÒ»´Î¡£ µãÆÀ£ºBL-8030Êǵڶþ´úHCVµ°°×øÒÖÖÆ¼Á£¬Æä»îÐÔºÍÑ¡ÔñÐÔÊDz»±ØËµµÄ£¬Ô¶ÓÅÓÚÒÑÉÏÊеÄtelaprevir¡£BL-8030µÄÁÁµãÊÇ£¨1£©Äܹ»¶Ô¿¹¸÷ÖÖÄÍÒ©Í»±ä£¨2£©¿ÉÒÔ¿Ú·þÇÒÿÌìÖ»Ðè¿Ú·þÒ»´Î£¨3£©Liver/plasma±ÈÖµ¸ß£¬°²È«ÐÔÓ¦¸Ã²»´í¡£ [ Last edited by ³ÕÃÎäìÏæ on 2013-6-12 at 21:48 ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÐÂÒ©·¢ÏÖ |
» ²ÂÄãϲ»¶
ÇóÖú£¡£¡£¡´óÀоÈÃü£¡£¡£¡
ÒѾÓÐ4È˻ظ´
õ£°·ËõºÏ
ÒѾÓÐ3È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ52È˻ظ´
ҩѧר˶µ÷¼Á
ÒѾÓÐ2È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
105500ҩѧµ÷¼Á£¬Ò»Ö¾Ô¸¶¥9£¬Ö÷³ÖÊ¡¼¶´ó´´£¬ÊµÑéÐÍSCI¶þ×÷£¬ËÄÁù¼¶Òѹý£¬Ë«¹ú½±
ÒѾÓÐ6È˻ظ´
ҩѧר˶µ÷¼Á
ÒѾÓÐ0È˻ظ´
publcifµÄʹÓÃ
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
»á¼Æ×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
ÒѾÓÐ10È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÖйúÖÆÒ©ÆóÒµ2013ÉϰëÄê½»Ò×¼ò±¨
ÒѾÓÐ4È˻ظ´
2013Äê6ÔÂÈ«ÇòÒ©Æó½»Ò×ÁÁµã
ÒѾÓÐ7È˻ظ´
¡ï
ºÓ±ßµÄ«Î: ½ð±Ò+1, ¸ÐлÄãµÄ»ØÌû½»Á÷~ 2013-07-02 15:07:55
ºÓ±ßµÄ«Î: »ØÌûÖö¥ 2013-07-02 15:08:06
ºÓ±ßµÄ«Î: ½ð±Ò+1, ¸ÐлÄãµÄ»ØÌû½»Á÷~ 2013-07-02 15:07:55
ºÓ±ßµÄ«Î: »ØÌûÖö¥ 2013-07-02 15:08:06
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
3Â¥2013-06-13 08:18:10
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
2Â¥2013-06-13 08:17:38
fw8505
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 2176.4
- É¢½ð: 9
- ºì»¨: 2
- Ìû×Ó: 932
- ÔÚÏß: 91.2Сʱ
- ³æºÅ: 813574
- ×¢²á: 2009-07-22
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
4Â¥2013-06-13 08:22:22
iamzane
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.7
- ½ð±Ò: 24626.1
- É¢½ð: 40
- ºì»¨: 21
- Ìû×Ó: 1974
- ÔÚÏß: 459.3Сʱ
- ³æºÅ: 330866
- ×¢²á: 2007-03-24
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
5Â¥2013-06-13 08:52:13













»Ø¸´´ËÂ¥